PierianDx
Belgian Society of Medical Oncology to Study Value of Genomic Profiling for Cancer Patients
The Belgian Society of Medical Oncology has partnered with Illumina, OncoDNA, and PierianDx for this study, which will enroll 864 patients with advanced metastatic cancer.